NCT07327775 Fibromyalgia Disease Burden in Mothers of Children With Attention-Deficit/Hyperactivity Disorder
| NCT ID | NCT07327775 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sultan 1. Murat State Hospital |
| Condition | Fibromyalgia Syndrome |
| Study Type | OBSERVATIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-12-26 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 100 participants in total. It began in 2025-12-26 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In this study, the investigators aimed to evaluate the impact of having a child diagnosed with Attention-Deficit/Hyperactivity Disorder (ADHD) on parental disease burden in mothers diagnosed with Fibromyalgia Syndrome (FMS). The study will include 50 mothers with FMS who have a child diagnosed with ADHD and 50 mothers with FMS who have children without any psychiatric disorders. Among mothers of children followed with a diagnosis of ADHD at the Child and Adolescent Psychiatry Outpatient Clinic of Edirne Sultan 1st Murat State Hospital, the presence of widespread body pain will be assessed. Mothers reporting widespread body pain will be referred to the Pain Management Outpatient Clinic of the same hospital for further evaluation for FMS. Mothers diagnosed with FMS will be included in the study group. The comparison group will consist of mothers with FMS who have children without any psychiatric disorders. These participants will be selected from patients diagnosed with FMS who present to the Pain Management Outpatient Clinic of Edirne Sultan 1st Murat State Hospital.
Eligibility Criteria
Inclusion Criteria: Inclusion Criteria for Participants with Children Diagnosed with ADHD: * Being a female aged between 18 and 50 years * Having one or more children aged 6-17 years diagnosed with Attention Deficit/Hyperactivity Disorder (ADHD) according to DSM-5 diagnostic criteria * Having a diagnosis of Fibromyalgia Syndrome (FMS according to the 2016 American College of Rheumatology \[ACR\] criteria) * Being literate Inclusion Criteria for Participants with Children Without Psychiatric Disorders: * Being a female aged between 18 and 50 years * Having one or more children aged 6-17 years without any psychiatric disorders * Having a diagnosis of Fibromyalgia Syndrome (FMS) according to the 2016 American College of Rheumatology (ACR) criteria * Being literate Exclusion Criteria: * Receiving regular pharmacological treatment for Fibromyalgia Syndrome * Having an active psychiatric disorder or using psychiatric medication * Having a history of infectious disease, chronic inflammatory disease, or malignancy * Being pregnant or breastfeeding * Having a central or peripheral nervous system disorder (e.g., cerebrovascular disease, multiple sclerosis) * Being uncooperative during clinical evaluation * Having comorbid conditions that may affect quality of life, including congestive heart failure, chronic kidney disease, chronic liver disease, pulmonary disease, uncontrolled diabetes mellitus, or peripheral vascular disease * Having a diagnosis of hypothyroidism or hyperthyroidism * Having substance use disorder or alcohol use disorder
Contact & Investigator
İbrahim Tiryaki, MD
PRINCIPAL INVESTIGATOR
Sultan 1. Murat State Hospital
Frequently Asked Questions
Who can join the NCT07327775 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 50 Years, studying Fibromyalgia Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07327775 currently recruiting?
Yes, NCT07327775 is actively recruiting participants. Contact the research team at a_mengi22@hotmail.com for enrollment information.
Where is the NCT07327775 trial being conducted?
This trial is being conducted at Edirne, Turkey (Türkiye).
Who is sponsoring the NCT07327775 clinical trial?
NCT07327775 is sponsored by Sultan 1. Murat State Hospital. The principal investigator is İbrahim Tiryaki, MD at Sultan 1. Murat State Hospital. The trial plans to enroll 100 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.